Cargando…

Ceragenin CSA-13 displays high antibacterial efficiency in a mouse model of urinary tract infection

Ceragenins (CSAs) are synthetic, lipid-based molecules that display activities of natural antimicrobial peptides. Previous studies demonstrated their high in vitro activity against pathogens causing urinary tract infections (UTIs), but their efficiency in vivo was not explored to date. In this study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wnorowska, Urszula, Piktel, Ewelina, Deptuła, Piotr, Wollny, Tomasz, Król, Grzegorz, Głuszek, Katarzyna, Durnaś, Bonita, Pogoda, Katarzyna, Savage, Paul B., Bucki, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649698/ https://www.ncbi.nlm.nih.gov/pubmed/36357517 http://dx.doi.org/10.1038/s41598-022-23281-y

Ejemplares similares

Ceragenins and Ceragenin-Based Core-Shell Nanosystems as New Antibacterial Agents against Gram-Negative Rods Causing Nosocomial Infections
por: Karasiński, Maciej, et al.
Publicado: (2023)

Candidacidal Activity of Selected Ceragenins and Human Cathelicidin LL-37 in Experimental Settings Mimicking Infection Sites
por: Durnaś, Bonita, et al.
Publicado: (2016)

Use of ceragenins as a potential treatment for urinary tract infections
por: Wnorowska, Urszula, et al.
Publicado: (2019)

Formulation and candidacidal activity of magnetic nanoparticles coated with cathelicidin LL-37 and ceragenin CSA-13
por: Niemirowicz, Katarzyna, et al.
Publicado: (2017)

Ceragenin CSA-13 as free molecules and attached to magnetic nanoparticle surfaces induce caspase-dependent apoptosis in human breast cancer cells via disruption of cell oxidative balance
por: Piktel, Ewelina, et al.
Publicado: (2018)

Sporicidal activity of ceragenin CSA-13 against Bacillus subtilis
por: Piktel, Ewelina, et al.
Publicado: (2017)

Targeting the Gut Microbiota to Relieve the Symptoms of Irritable Bowel Syndrome
por: Wollny, Tomasz, et al.
Publicado: (2021)

Bactericidal Activity of Ceragenin in Combination with Ceftazidime, Levofloxacin, Co-Trimoxazole, and Colistin against the Opportunistic Pathogen Stenotrophomonas maltophilia
por: Paprocka, Paulina, et al.
Publicado: (2022)

Anaerobic bacteria growth in the presence of cathelicidin LL-37 and selected ceragenins delivered as magnetic nanoparticles cargo
por: Durnaś, Bonita, et al.
Publicado: (2017)

NDM-1 Carbapenemase-Producing Enterobacteriaceae are Highly Susceptible to Ceragenins CSA-13, CSA-44, and CSA-131
por: Chmielewska, Sylwia Joanna, et al.
Publicado: (2020)

Core–shell magnetic nanoparticles display synergistic antibacterial effects against Pseudomonas aeruginosa and Staphylococcus aureus when combined with cathelicidin LL-37 or selected ceragenins
por: Niemirowicz, Katarzyna, et al.
Publicado: (2016)

Peanut-Shaped Gold Nanoparticles with Shells of Ceragenin CSA-131 Display the Ability to Inhibit Ovarian Cancer Growth In Vitro and in a Tumor Xenograft Model
por: Piktel, Ewelina, et al.
Publicado: (2021)

Mechanical Properties of the Extracellular Environment of Human Brain Cells Drive the Effectiveness of Drugs in Fighting Central Nervous System Cancers
por: Cieśluk, Mateusz, et al.
Publicado: (2022)

Ceragenin-Coated Non-Spherical Gold Nanoparticles as Novel Candidacidal Agents
por: Skłodowski, Karol, et al.
Publicado: (2021)

Sphingosine-1-Phosphate-Triggered Expression of Cathelicidin LL-37 Promotes the Growth of Human Bladder Cancer Cells
por: Wollny, Tomasz, et al.
Publicado: (2022)

Assessment of Ceragenins in Prevention of Damage to Voice Prostheses Caused by Candida Biofilm Formation
por: Spałek, Jakub, et al.
Publicado: (2021)

Bactericidal Properties of Rod-, Peanut-, and Star-Shaped Gold Nanoparticles Coated with Ceragenin CSA-131 against Multidrug-Resistant Bacterial Strains
por: Chmielewska, Sylwia Joanna, et al.
Publicado: (2021)

Quantification of Synergistic Effects of Ceragenin CSA-131 Combined with Iron Oxide Magnetic Nanoparticles Against Cancer Cells
por: Piktel, Ewelina, et al.
Publicado: (2020)

Bactericidal activity and biocompatibility of ceragenin-coated magnetic nanoparticles
por: Niemirowicz, Katarzyna, et al.
Publicado: (2015)

The Role of Cathelicidin LL-37 in Cancer Development
por: Piktel, Ewelina, et al.
Publicado: (2015)

Ceragenin CSA-44 as a Means to Control the Formation of the Biofilm on the Surface of Tooth and Composite Fillings
por: Tokajuk, Joanna, et al.
Publicado: (2022)

Bactericidal and immunomodulatory properties of magnetic nanoparticles functionalized by 1,4-dihydropyridines
por: Niemirowicz-Laskowska, Katarzyna, et al.
Publicado: (2018)

Recombinant Human Plasma Gelsolin Stimulates Phagocytosis while Diminishing Excessive Inflammatory Responses in Mice with Pseudomonas aeruginosa Sepsis
por: Piktel, Ewelina, et al.
Publicado: (2020)

Nanoantibiotics containing membrane-active human cathelicidin LL-37 or synthetic ceragenins attached to the surface of magnetic nanoparticles as novel and innovative therapeutic tools: current status and potential future applications
por: Wnorowska, Urszula, et al.
Publicado: (2020)

Inhomogeneity of stiffness and density of the extracellular matrix within the leukoplakia of human oral mucosa as potential physicochemical factors leading to carcinogenesis
por: Pogoda, Katarzyna, et al.
Publicado: (2021)

Antibacterial and Antifungal Activities of Poloxamer Micelles Containing Ceragenin CSA-131 on Ciliated Tissues
por: Hashemi, Marjan M., et al.
Publicado: (2018)

New β-Lactam Antibiotics and Ceragenins – A Study to Assess Their Potential in Treatment of Infections Caused by Multidrug-Resistant Strains of Pseudomonas aeruginosa
por: Paprocka, Paulina, et al.
Publicado: (2021)

Sphingosine-1-Phosphate Metabolism and Its Role in the Development of Inflammatory Bowel Disease
por: Wollny, Tomasz, et al.
Publicado: (2017)

Inhibition of inflammatory response in human keratinocytes by magnetic nanoparticles functionalized with PBP10 peptide derived from the PIP2-binding site of human plasma gelsolin
por: Piktel, Ewelina, et al.
Publicado: (2019)

Hypogelsolinemia and Decrease in Blood Plasma Sphingosine-1-Phosphate in Patients Diagnosed with Severe Acute Pancreatitis
por: Wollny, Tomasz, et al.
Publicado: (2021)

Defective Sphingolipids Metabolism and Tumor Associated Macrophages as the Possible Links Between Gaucher Disease and Blood Cancer Development
por: Wątek, Marzena, et al.
Publicado: (2019)

Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy
por: Piktel, Ewelina, et al.
Publicado: (2016)

Glyoxylate Shunt and Pyruvate-to-Acetoin Shift Are Specific Stress Responses Induced by Colistin and Ceragenin CSA-13 in Enterobacter hormaechei ST89
por: Prasad, Suhanya V., et al.
Publicado: (2023)

Biocompatible Materials in Otorhinolaryngology and Their Antibacterial Properties
por: Spałek, Jakub, et al.
Publicado: (2022)

Pseudomonas aeruginosa Infections in Cancer Patients
por: Paprocka, Paulina, et al.
Publicado: (2022)

Susceptibility of microbial cells to the modified PIP(2)-binding sequence of gelsolin anchored on the surface of magnetic nanoparticles
por: Bucki, Robert, et al.
Publicado: (2019)

Hypogelsolinemia in Patients Diagnosed with Acute Myeloid Leukemia at Initial Stage of Sepsis
por: Wątek, Marzena, et al.
Publicado: (2019)

Magnetic nanoparticles enhance the anticancer activity of cathelicidin LL-37 peptide against colon cancer cells
por: Niemirowicz, Katarzyna, et al.
Publicado: (2015)

Plasma Gelsolin: Indicator of Inflammation and Its Potential as a Diagnostic Tool and Therapeutic Target
por: Piktel, Ewelina, et al.
Publicado: (2018)

Tissue Rheology as a Possible Complementary Procedure to Advance Histological Diagnosis of Colon Cancer
por: Deptuła, Piotr, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3f9k4tu2bjhoqti0ce0cu0uvm0